1. Microbiology and Infectious Disease
Download icon

Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs

Research Article
  • Cited 16
  • Views 1,865
  • Annotations
Cite this article as: eLife 2015;4:e09115 doi: 10.7554/eLife.09115

Abstract

Persistent reservoirs remain the major obstacles to achieve an HIV-1 cure. Prolonged early antiretroviral therapy (ART) may reduce the extent of reservoirs and allow for virological control after ART discontinuation. We compared HIV-1 reservoirs in a cross-sectional study using PCR-based techniques in blood and tissue of early treated seroconverters, late treated patients, ART-naïve seroconverters and long-term non-progressors (LTNPs) who have spontaneous virological control without treatment. A decade of early ART reduced total and integrated HIV-1 DNA levels compared to later treatment initiation, but not reaching the low levels of LTNPs. Total HIV-1 DNA in rectal biopsies did not differ between cohorts. Importantly, lower viral transcription (unspliced RNA) and enhanced immune preservation (CD4/CD8) reminiscent of LTNPs were found in early compared to late treated patients. This suggests that early treatment is associated with some immuno-virological features of LTNPs that may improve the outcome of future interventions aimed at a functional cure.

Article and author information

Author details

  1. Eva Malatinkova

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  2. Ward De Spiegelaere

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  3. Pawel Bonczkowski

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  4. Maja Kiselinova

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  5. Karen Vervisch

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  6. Wim Trypsteen

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  7. Margaret Johnson

    Division of Infection and Immunity, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Chris Verhofstede

    AIDS Reference Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. Danny de Looze

    Department of Gastroenterology, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  10. Charles Murray

    Department of Gastroenterology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Sabine Kinloch-de Loes

    Division of Infection and Immunity, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Linos Vandekerckhove

    HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitair Ziekenhuis Gent, Ghent University, Ghent, Belgium
    For correspondence
    linos.vandekerckhove@ugent.be
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Human subjects: Patient written informed consent was obtained from all the study participants.The study was approved by the Ethical Committee of Ghent University Hospital (Reference number: B670201317826) and Royal Free Hospital (Reference number: 13/LO/0729).

Reviewing Editor

  1. Quarraisha Abdool Karim, University of KwaZulu Natal, South Africa

Publication history

  1. Received: June 5, 2015
  2. Accepted: October 1, 2015
  3. Accepted Manuscript published: October 6, 2015 (version 1)
  4. Version of Record published: November 17, 2015 (version 2)

Copyright

© 2015, Malatinkova et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,865
    Page views
  • 357
    Downloads
  • 16
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)